Effects of peripheral-type benzodiazepine receptor ligands on Ehrlich tumor cell proliferation

European Journal of Pharmacology

Volumn 550, Issue 1-3, 2006, Pages 8-14

  Sakai, Mônica ^a   Fonseca, Evelise Souza Monteiro ^a   Oloris, Silvia Catarina Salgado ^a   Matsuzaki, Patrícia ^a   Otake, Andréia Hanada ^a   Leite, Kátia Ramos Moura ^b   Massoco, Cristina Oliveira ^b   Dagli, Maria Lúcia Zaidan ^a   Palermo Neto, João ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b HOSPITAL SÍRIO LIBANÊS   (Brazil)

Author keywords

Cancer; Diazepam; Ehrlich tumor; Peripheral type benzodiazepine receptor; Proliferation; Ro5 4864

Indexed keywords

4' CHLORODIAZEPAM; BENZODIAZEPINE RECEPTOR; CLONAZEPAM; DIAZEPAM; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL NUCLEUS; CELL PROLIFERATION; CONTROLLED STUDY; EHRLICH ASCITES TUMOR CELL; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BENZODIAZEPINONES; CARCINOMA, EHRLICH TUMOR; CELL CYCLE; CELL DIVISION; CELL PROLIFERATION; CLONAZEPAM; FLOW CYTOMETRY; GABA MODULATORS; IMMUNOHISTOCHEMISTRY; ISOQUINOLINES; LIGANDS; MICE; RECEPTORS, GABA-A;

EID: 33750017622     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.07.057     Document Type: Article

References (45)

1. Alexander B.E., Roller E., and Klotz U. Characterization of peripheral-type benzodiazepine binding sites on human lymphocytes and lymphoma cell lines and their role in cell growth. Biochem. Pharmacol. 44 (1992) 269-274
2. Bairy K.L., Sanath S., Jagetia G.C., Somayaji S.N., Vidyasagar M.S., and Baliga M.S. Evaluation of intraperitoneal vincristine in malignant peritoneal effusion. Indian J. Physiol. Pharmacol. 47 (2003) 270-278
3. Beinlich A., Strohmeier R., Kaufmann M., and Kuhl H. Specific binding of benzodiazepines to human breast cancer cell lines. Life Sci. 65 (1999) 2099-2108
4. Beinlich A., Strohmeier R., Kaufmann M., and Kuhl H. Relation of cell proliferation to expression of peripheral benzodiazepine receptors in human breast cancer cell lines. Biochem. Pharmacol. 60 (2000) 397-402
5. Bribes E., Bourrie B., and Casellas P. Ligands of the peripheral benzodiazepine receptor have therapeutic effects in pneumopathies in vivo. Immunol. Lett. 88 (2003) 241-247
6. Brown R.C., and Papadopoulos V. Role of the peripheral-type benzodiazepine receptor in adrenal and brain steroidogenesis. Int. Rev. Neurobiol. 46 (2001) 117-143
7. Brown R.C., Degenhardt B., Kotoula M., and Papadopoulous V. Location-dependent role of the human glioma cell peripheral-type benzodiazepine receptor in proliferation and steroid biosynthesis. Cancer Lett. 156 (2000) 125-132
8. Carmel I., Fares F.A., Leschiner S., Scherubl H., Weisinger G., and Gavish M. Peripheral-type benzodiazepine receptors in the regulation of proliferation of MCF-7 human breast carcinoma cell line. Biochem. Pharmacol. 58 (1999) 273-278
9. Corsi L., Geminiani E., Avallone R., and Baraldi M. Nuclear location-dependent role of peripheral benzodiazepine receptor (PBR) in hepatic tumoral cell lines proliferation. Life Sci. 76 (2005) 2523-2533
10. Costa E., Guidotti A., Mao C.C., and Suria A. New concepts on the mechanism of action of benzodiazepines. Life Sci. 17 (1975) 167-185
11. Galiegue S., Tinel N., and Casellas P. The peripheral benzodiazepine receptor: a promising therapeutic drug target. Curr. Med. Chem. 10 (2003) 1563-1572
12. Galiegue S., Casellas P., Kramar A., Tinel N., and Simony-Lafontaine J. Immunohistochemical assessment of the peripheral benzodiazepine receptor in breast cancer and its relationship with survival. Clin. Cancer Res. 10 (2004) 2058-2064
13. Gavish M., Katz Y., Bar-Ami S., and Weizman R. Biochemical, physiological, and pathological aspects of the peripheral benzodiazepine receptor. J. Neurochem. 58 (1992) 1589-1601
14. Han Z., Slack R.S., Li W., and Papadopoulos V. Expression of peripheral benzodiazepine receptor (PBR) in human tumors: relationship to breast, colorectal, and prostate tumor progression. J. Recept. Signal Transduct. Res. 23 (2003) 225-238
15. Hardwick M., Fertikh D., Culty M., Li H., Vidic B., and Papadopoulos V. Peripheral-type benzodiazepine receptor (PBR) in human breast cancer: correlation of breast cancer cell aggressive phenotype with PBR expression, nuclear localization, and PBR-mediated cell proliferation and nuclear transport of cholesterol. Cancer Res. 59 (1999) 831-842
16. Katz Y., Ben-Baruch G., Kloog Y., Menczer J., and Gavish M. Increased density of peripheral benzodiazepine-binding sites in ovarian carcinomas as compared with benign ovarian tumours and normal ovaries. Clin. Sci. (Lond) 78 (1990) 155-158
17. Katz Y., Eitan A., and Gavish M. Increase in peripheral benzodiazepine binding sites in colonic adenocarcinoma. Oncology 47 (1990) 139-142
18. Kletsas D., Li W., Han Z., and Papadopoulos V. Peripheral-type benzodiazepine receptor (PBR) and PBR drug ligands in fibroblast and fibrosarcoma cell proliferation: role of ERK, c-Jun and ligand-activated PBR-independent pathways. Biochem. Pharmacol. 67 (2004) 1927-1932
19. Knibbs R.N., MacCallum D.K., Lillie J.H., and Goldstein I.J. Wild-type and cultured Ehrlich ascites tumour cells differ in tumorigenicity, lectin binding patterns and binding to basement membranes. Glycobiology 4 (1994) 419-428
20. Landau M., Weizman A., Zoref-Shani E., Beery E., Wasseman L., Landau O., Gavish M., Brenner S., and Nordenberg J. Antiproliferative and differentiating effects of benzodiazepine receptor ligands on B16 melanoma cells. Biochem. Pharmacol. 56 (1998) 1029-1034
21. Lee D.H., Kang S.K., Lee R.H., Ryu J.M., Park H.Y., Choi H.S., Bae Y.C., Suh K.T., Kim Y.K., and Jung J.S. Effects of peripheral benzodiazepine receptor ligands on proliferation and differentiation of human mesenchymal stem cells. J. Cell. Physiol. 198 (2004) 91-99
22. Li H., and Papadopoulos V. Peripheral-type benzodiazepine receptor function in cholesterol transport. Identification of a putative cholesterol recognition/interaction amino acid sequence and consensus pattern. Endocrinology 139 (1998) 4991-4997
23. Maaser K., Sutter A.P., Krahn A., Hopfner M., Grabowski P., and Scherubl H. Cell cycle-related signaling pathways modulated by peripheral benzodiazepine receptor ligands in colorectal cancer cells. Biochem. Biophys. Res. Commun. 324 (2004) 878-886
24. Maaser K., Grabowski P., Oezdem Y., Krahn A., Heine B., Stein H., Buhr H., Zeitz M., and Scherubl H. Up-regulation of the peripheral benzodiazepine receptor during human colorectal carcinogenesis and tumor spread. Clin. Cancer Res. 11 (2005) 1751-1756
25. Matsuya Y., and Yamane I. Increased tumorigenicity of polyploid Ehrlich variants during growth in vivo is associated with karyotypic changes. Eur. J. Cancer Clin. Oncol. 23 (1987) 675-682
26. Matsuzaki P., Akisue G., Salgado Oloris S.C., Gorniak S.L., and Zaidan Dagli M.L. Effect of Pfaffia paniculata (Brazilian ginseng) on the Ehrlich tumor in its ascitic form. Life Sci. 74 (2003) 573-579
27. Miettinen H., Kononen J., Haapasalo H., Helen P., Sallinen P., Harjuntausta T., Helin H., and Alho H. Expression of peripheral-type benzodiazepine receptor and diazepam binding inhibitor in human astrocytomas: relationship to cell proliferation. Cancer Res. 55 (1995) 2691-2695
28. Obrador E., Carretero J., Esteve J.M., Pellicer J.A., Pascual A., Petschen I., and Estrela J.M. Glutamine potentiates TNF-alpha-induced tumor cytotoxicity. Free Radic. Biol. Med. 31 (2001) 642-650
29. Papadopoulos V. Peripheral benzodiazepine receptor: structure and function in health and disease. Ann. Pharm. Fr. 61 (2003) 30-50
30. Papadopoulos V. In search of the function of the peripheral-type benzodiazepine receptor. Endocr. Res. 30 (2004) 677-684
31. Papadopoulos V., Mukhin A.G., Costa E., and Krueger K.E. The peripheral-type benzodiazepine receptor is functionally linked to Leydig cell steroidogenesis. J. Biol. Chem. 265 (1990) 3772-3779
32. Papadopoulos V., Amri H., Li H., Yao Z., Brown R.C., Vidic B., and Culty M. Structure, function and regulation of the mitochondrial peripheral-type benzodiazepine receptor. Therapie 56 (2001) 549-556
33. Ruiz I., Offermanns J., Lanctot K.L., and Busto U. Comparative study on benzodiazepine use in Canada and Chile. J. Clin. Pharmacol. 33 (1993) 124-129
34. Sakai M., Fonseca E.S.M., Dagli M.L.Z., and Palermo-Neto J. Diazepam effects on Ehrlich tumor growth and macrophage activity in mice. Life Sci. 78 (2006) 1777-1783
35. Salgado Oloris S.C., Dagli M.L., and Guerra J.L. Effect of beta-carotene on the development of the solid Ehrlich tumor in mice. Life Sci. 71 (2002) 717-724
36. Sanger N., Strohmeier R., Kaufmann M., and Kuhl H. Cell cycle-related expression and ligand binding of peripheral benzodiazepine receptor in human breast cancer cell lines. Eur. J. Cancer 36 (2000) 2157-2163
37. Stiefel F., Berney A., and Mazzocato C. Psychopharmacology in supportive care in cancer: a review for the clinician. I. Benzodiazepines. Support. Care Cancer 7 (1999) 379-385
38. Stoebner P.E., Carayon P., Penarier G., Frechin N., Barneon G., Casellas P., Cano J.P., Meynadier J., and Meunier L. The expression of peripheral benzodiazepine receptors in human skin: the relationship with epidermal cell differentiation. Br. J. Dermatol. 140 (1999) 1010-1016
39. Sutter A.P., Maaser K., Grabowski P., Bradacs G., Vormbrock K., Hopfner M., Krahn A., Heine B., Stein H., Somasundaram R., Schuppan D., Zeitz M., and Scherubl H. Peripheral benzodiazepine receptor ligands induce apoptosis and cell cycle arrest in human hepatocellular carcinoma cells and enhance chemosensitivity to paclitaxel, docetaxel, doxorubicin and the Bcl-2 inhibitor HA14-1. J. Hepatol. 41 (2004) 799-807
40. Venturini I., Zeneroli M.L., Corsi L., Avallone R., Farina F., Alho H., Baraldi C., Ferrarese C., Pecora N., Frigo M., Ardizzone G., Arrigo A., Pellicci R., and Baraldi M. Up-regulation of peripheral benzodiazepine receptor system in hepatocellular carcinoma. Life Sci. 63 (1998) 1269-1280
41. Venturini I., Alho H., Podkletnova I., Corsi L., Rybnikova E., Pellicci R., Baraldi M., Pelto-Huikko M., Helen P., and Zeneroli M.L. Increased expression of peripheral benzodiazepine receptors and diazepam binding inhibitor in human tumors sited in the liver. Life Sci. 65 (1999) 2223-2231
42. Wang J.K., Morgan J.I., and Spector S. Benzodiazepines that bind at peripheral sites inhibit cell proliferation. Proc. Natl. Acad. Sci. U. S. A. 81 (1984) 753-756
43. Zavala F. Benzodiazepines, anxiety and immunity. Pharmacol. Ther. 75 (1997) 199-216
44. Zilz A., Li H., Castello R., Papadopoulos V., and Widmaier E.P. Developmental expression of the peripheral-type benzodiazepine receptor and the advent of steroidogenesis in rat adrenal glands. Endocrinology 140 (1999) 859-864
45. Zisterer D.M., Hance N., Campiani G., Garofalo A., Nacci V., and Williams D.C. Antiproliferative action of pyrrolobenzoxazepine derivatives in cultured cells: absence of correlation with binding to the peripheral-type benzodiazepine binding site. Biochem. Pharmacol. 55 (1998) 397-403